Sevoflurane for sedation in septic shock ICU patients
Treatments studied
Part of Infections clinical trials.
This Phase 2 study tests whether a specific inhaled sedative (sevoflurane) is safe and helpful for people with septic shock who need ICU sedation and a breathing machine. It may improve how patients tolerate intensive care treatment, but eligibility is limited to a short time window after septic shock begins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 80 years old
- You’re in the ICU with septic shock even after fluids, and you need medicines (vasopressors) to keep blood pressure up
- You started this ICU septic shock treatment within the last 12 hours
- You’re already receiving ICU sedation and a breathing machine
- If you can become pregnant: you have a negative pregnancy test
- You can give consent (or your legal representative can)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests whether inhaled sevoflurane (a breathing anesthetic) can help prevent ARDS, a serious lung injury, in high-risk ICU patients who need sedation. It aims to reduce the chance of developing ARDS by using this medication during the early period on a breathing machine.
This study is testing a sedative medicine (sevoflurane) to help people with a difficult airway breathe more easily during a procedure. It may be an alternative to being awake while a tube is placed in your windpipe.
This trial compares inhaled isoflurane sedation to standard propofol sedation in deeply sedated patients on ventilators. It aims to see if inhaled sedation improves outcomes.
This Phase 3 trial tests a sedation approach using inhaled (“volatile”) anesthesia gases for children who need a ventilator. It aims to improve comfort and brain-related outcomes while they stay on the breathing machine for at least a day.
This trial tests if an inhaled sedative called isoflurane can be used safely and effectively in people who are on a heart-lung machine (ECMO) for severe heart failure (cardiogenic shock) and also need a breathing tube. It compares isoflurane to standard sedatives (propofol and midazolam).
This trial is comparing a new type of inhaled sedative (volatile sedation) to usual IV sedatives for people with ARDS who are on a ventilator in the ICU. It aims to see if it can help patients breathe better and recover more quickly.
Hear when a new Shock, Septic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.